New service leverages speech recognition and generative AI to automatically create preliminary clinical documentation from patient-clinician conversations ...
Analyses Show Oral Bridging Maintains Virologic Suppression When Subcutaneous Lenacapavir Doses are Missed – Gilead Sciences, Inc. (Na...
IntelGenx Corp. (TSX:IGX)(OTCQB:IGXT) (the "Company" or "IntelGenx") announced the execution of a Research Grant Agreement with Karolinska Unive...
SQZ Biotechnologies Company (OTC: SQZB) (the “Company” or “SQZ”) announced that Roche has determined that it will not exercis...
The FDA clearance also includes the company's core technology platform, the proprietary AXINON® System, that incorporates diagnostic testing algor...
India based Lupin Digital Health and the American College of Cardiology (ACC) have announced a first-of-its-kind collaboration to deliver in-home cardiovas...
Those interested in listening to the conference call should register online here. Participants are encouraged to register more than 15 minutes before the s...
The partners continue working closely on matters concerning pending approval in the U.S. for AVT02, an interchangeable high-concentration biosimilar candid...
Collaboration Combines ImmunoGen's Proprietary Linker-Payload Technology with Antibodies Developed by ImmunoBiochem Agreement Grants ImmunoGen an Exclusiv...
Baxter International Inc. (NYSE:BAX), a global leader in advancing surgical innovation, today announced the launch of PERCLOT Absorbable Hemostatic Powder ...
Each year in Europe more than 550,000 patients are diagnosed with breast cancer, of whom 70% have estrogen receptor (ER)-positive disease¹; more tha...
What if there was a solution? A golden key or antidote to lift the fog and restore your mind? How far would you go to obtain it? And if it doesn't ...
Magrolimab is a potential first-in-class, anti-CD47 immunotherapy with a clinical development program spanning ten potential indications including ongoing ...
Novel antibody specifically designed for oral administration utilizes Tillotts Pharma’s sustained release approach to ensure optimal and local trea...
© 2025 Biopharma Boardroom. All Rights Reserved.
